EyePoint, Inc. - Common Stock (EYPT)

Historical Holders from Q4 2020 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
EYPT on Nasdaq
Shares outstanding
82,815,631
Price per share
$18.27
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
69,367,962
Holdings value
$987,669,513
% of all portfolios
0%
Share change
+745,973
Value change
+$20,151,545
Average buys %
+0%
Average sells %
-0%
Number of holders
147
Price from insider filings
$16.86
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of EyePoint, Inc. - Common Stock (EYPT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Cormorant Asset Management, LP 10% $121,826,100 8,265,000 Cormorant Asset Management, LP 04 Dec 2025
Adage Capital Management, L.P. 8.1% -18% $79,171,296 -$17,660,704 5,559,782 -18% Adage Capital Management, L.P. 30 Sep 2025
FEDERATED HERMES, INC. 6.7% $27,182,750 4,599,450 Federated Hermes, Inc. 30 Jun 2025
BlackRock, Inc. 6.5% $63,872,124 4,485,402 BlackRock, Inc. 30 Sep 2025
FRANKLIN RESOURCES INC 6.1% -18% $19,115,560 +$579,898 4,137,567 +3.1% Franklin Resources, Inc. 31 Dec 2024
RA CAPITAL MANAGEMENT, L.P. 4.7% $14,699,999 3,181,818 RA Capital Management, L.P. 31 Dec 2024
As of 30 Sep 2025, EyePoint, Inc. - Common Stock (EYPT) has 147 institutional shareholders filing 13F forms. They hold 69,367,962 shares of 82,815,631 outstanding shares (84%) .

Top 25 institutional shareholders own 73% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
Cormorant Asset Management, LP 10% 8,325,000 0% 8.2% $118,548,000
SUVRETTA CAPITAL MANAGEMENT, LLC 7.5% 6,192,715 -9% 2.7% $88,184,262
ADAGE CAPITAL PARTNERS GP, L.L.C. 6.7% 5,559,782 -18% 0.13% $79,171,296
BlackRock, Inc. 6% 4,964,526 -7.4% 0% $70,694,849
FEDERATED HERMES, INC. 5.3% 4,416,332 -4% 0.11% $62,888,567
FRANKLIN RESOURCES INC 5% 4,171,884 -3% 0.01% $59,407,621
VANGUARD GROUP INC 4.6% 3,794,516 -0.21% 0% $54,033,908
TCG Crossover Management, LLC 4.3% 3,572,335 0% 2.5% $50,870,050
CITADEL ADVISORS LLC 2.6% 2,135,389 -8.9% 0.02% $30,407,939
Paradigm Biocapital Advisors LP 2.4% 2,005,365 0.84% $28,556,398
ORBIMED ADVISORS LLC 2.2% 1,796,000 0.61% $25,575,040
GEODE CAPITAL MANAGEMENT, LLC 1.8% 1,524,526 -4.2% 0% $21,714,141
GOLDMAN SACHS GROUP INC 1.8% 1,514,606 +18% 0% $21,567,990
STATE STREET CORP 1.8% 1,473,199 -2.8% 0% $20,978,354
Essex Woodlands Management, Inc. 1.3% 1,084,857 -7.3% 5% $15,448,362
5AM Venture Management, LLC 1.3% 1,050,000 0% 5.5% $14,952,000
Patient Square Capital LP 1.2% 1,011,839 -25% 3.9% $14,408,587
BANK OF AMERICA CORP /DE/ 1.2% 1,010,331 +24% 0% $14,387,118
MORGAN STANLEY 1.2% 978,129 +25% 0% $13,928,557
Aberdeen Group plc 0.96% 796,802 -23% 0.02% $11,346,460
Balyasny Asset Management L.P. 0.91% 756,087 0.02% $10,766,679
HSBC HOLDINGS PLC 0.87% 716,453 +14% 0.01% $10,209,953
Rosalind Advisors, Inc. 0.78% 650,000 3.4% $9,256,000
Artia Global Partners LP 0.76% 628,367 +98% 1.6% $8,947,946
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.64% 531,723 +180% 0% $7,571,736

Institutional Holders of EyePoint, Inc. - Common Stock (EYPT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 37,079 $677,809 -$81,461 $18.27 5
2025 Q3 69,367,962 $987,669,513 +$20,151,545 $14.24 147
2025 Q2 68,912,118 $648,484,078 -$21,934,697 $9.41 139
2025 Q1 74,070,140 $401,203,735 -$6,558,649 $5.42 149
2024 Q4 74,297,439 $553,342,031 +$114,449,216 $7.45 141
2024 Q3 58,498,731 $476,138,729 -$4,309,954 $7.99 136
2024 Q2 58,402,646 $508,095,413 +$27,449,930 $8.70 150
2024 Q1 5,119,174 $105,809,530 -$41,155,396 $20.67 30
2023 Q4 34,731 $802,633 -$577,265 $23.11 2
2023 Q3 33,692,370 $269,202,861 +$16,723,553 $7.99 97
2023 Q2 31,573,084 $274,684,950 +$22,852,983 $8.70 82
2023 Q1 29,111,470 $85,591,090 -$1,205,999 $2.94 66
2022 Q4 29,367,668 $102,783,000 -$6,522,140 $3.50 71
2022 Q3 29,222,642 $231,148,498 +$33,401 $7.91 79
2022 Q2 29,188,976 $229,719,742 +$661,136 $7.87 75
2022 Q1 30,141,798 $366,292,357 +$7,719,907 $12.15 74
2021 Q4 29,823,450 $365,169,130 +$95,140,574 $12.24 85
2021 Q3 22,119,997 $230,462,815 +$15,007,325 $10.42 62
2021 Q2 20,739,059 $186,447,743 +$7,943,490 $8.99 60
2021 Q1 19,642,172 $199,572,620 +$124,369,861 $10.16 58
2020 Q4 7,703,318 $50,684,935 +$50,684,818 $6.58 33